New research suggests that drugs like Ozempic and Wegovy might trigger more than just a slimmer waistline. Many users have ...
Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, Novo Nordisk said.
Next-generation weight loss pills are expected to hit the market next year, and drugmakers are working on medications with ...
Novo Nordisk A/S (NYSE:NVO) is one of the Best Very Cheap Stocks to Invest In. On November 24, Richard Vosser from J.P.
Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain ...
Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...
The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...
Eli Lilly and Co. on Friday, Nov. 21 became the first health care company to surpass a $1 trillion market valuation, driven ...
Novo Nordisk is seeking FDA approval for a 7.2 mg dose of Wegovy, nearly three times the current maximum dose. The ...
Also in September, Danish pharmaceutical company Novo Nordisk said it would cut 9,000 jobs, about 11% of its workforce. The ...
The Trump administration’s negotiation with Novo Nordisk A/S that slashes 71% off the list price of its blockbusters Ozempic ...
The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results